Evaluation of a New Cardiac Biomarker Assay

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1101 participants.

Also called NCT01608100

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 1,101 participants (enrolled count) (from the registry)
Sponsor
Abbott Diagnostics Division (from the registry)
Registry
  • NCT NCT01608100
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01608100. Allocation not applicable; no masking; primary purpose diagnostic. Start 2012-06 (registry gives no type); primary completion 2014-08 (actual). Results posted on 2015-03-17.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of a New Cardiac Biomarker Assay
Condition
Acute Coronary Syndrome
Condition
Acute Myocardial Infarction
Intervention (Device)
ARCHITECT STAT High Sensitive Troponin I Assay
Lead sponsor
Abbott Diagnostics Division (class: industry)

Record details

Record id
cardio:ct-nct01608100
Content hash
6af7160abd5f68dde54bb4981ce6d37a293a415a85c916421db30195744a7db9